European Union Collaboration
MSInsight is proud to be a contributing partner in PREDI-LYNCH, a six-year, €13.6 million Horizon Europe-funded initiative led by Oslo […]
Catégorie : Medical
New publication on prediction of response to immune checkpoint blockade in patients with metastatic colorectal cancer with microsatellite instability
👏 Thrilled to share a tremendous achievement with our contribution to an article accepted in Annals of Oncology🔍 This publication emphasizes […]
SFMPP Axel Khan Award to our CTO, Toky Ratovomanana, for his work on prediction to response to immunotherapy for MSI metastatic colorectal cancer
🏆 Our partner from CRSA PARIS and our CTO Toky Ratovomanana have been honored with the prestigious Axel Kahn Award by the SFMPP – Société […]
Alex Duval, CSO of MSInsight, laureat of Raymond Rosen Prize from the Fondation pour la Recherche Médicale
🏅 Great News! Our CSO and co-founder, Alex Duval, has been awarded the 2023 Raymond Rosen Prize by the Fondation pour […]
Meet our team at the national congress on tumor with microsatellite instability
📢 MSInsight will be present at the very first national inter-SiRIC congress dedicated to microsatellite instability (MSI) cancers. Join us to exchange […]
MSInsight in the spolight of BigBooster
🌍 We’re thrilled to announce that MSInsight has been selected among the startups of season 7 of the prestigious international acceleration program, BigBooster. This […]
Biologiste 365
MSInsight explores the diagnostic potential of microsatellites MSInsight is proud to be featured on Biologiste365, where we share our innovative […]
Hello Tomorrow
MSInsight Named a Deep Tech Pioneer by Hello Tomorrow! We are proud to announce that MSInsight has been selected as […]
MSInsight Receives hi France Label
🌟 We are thrilled to announce that MSInsight has been awarded the prestigious hi France label by the MEDICEN competitiveness […]
